{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADACEL%C2%AE&page=2", "query": { "intervention": "ADACEL®", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADACEL%C2%AE&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T21:38:56.570Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00614614", "title": "Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix)", "type": "BIOLOGICAL" }, { "name": "Infanrix®", "type": "BIOLOGICAL" }, { "name": "ActHIB®", "type": "BIOLOGICAL" }, { "name": "Pediarix®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1558, "start_date": "2008-02-13", "completion_date": "2009-09-17", "has_results": true, "last_update_posted_date": "2018-09-21", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Benton, Arkansas + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00614614" }, { "nct_id": "NCT00474526", "title": "A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis, Meningococcal" ], "interventions": [ { "name": "Meningococcal ACWY Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV-HBV", "type": "BIOLOGICAL" }, { "name": "Hib", "type": "BIOLOGICAL" }, { "name": "Rotavirus", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 7-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "HAV", "type": "BIOLOGICAL" }, { "name": "MMR-V", "type": "BIOLOGICAL" }, { "name": "DTaP", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Months", "maximum_age": "2 Months", "sex": "ALL", "summary": "2 Months to 2 Months" }, "enrollment_count": 4545, "start_date": "2007-03", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2014-03-24", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 53, "location_summary": "Bessemer, Alabama • Birmingham, Alabama • Downey, California + 43 more", "locations": [ { "city": "Bessemer", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Downey", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00474526" }, { "nct_id": "NCT00802867", "title": "Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diphtheria", "Tetanus", "Pertussis", "Polio", "Haemophilus Infection" ], "interventions": [ { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 989, "start_date": "2004-02", "completion_date": "2005-09", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 19, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • Oakland, California + 16 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00802867" }, { "nct_id": "NCT02052596", "title": "Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Zoster" ], "interventions": [ { "name": "Herpes Zoster vaccine GSK 1437173A", "type": "BIOLOGICAL" }, { "name": "Boostrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 935, "start_date": "2014-02-07", "completion_date": "2016-04-21", "has_results": true, "last_update_posted_date": "2018-04-24", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 13, "location_summary": "Tucson, Arizona • San Diego, California • Stockbridge, Georgia + 9 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Meridian", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT02052596" }, { "nct_id": "NCT01000974", "title": "Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)", "type": "BIOLOGICAL" }, { "name": "ActHIB™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "Pediarix™", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "Rotarix™", "type": "BIOLOGICAL" }, { "name": "Engerix™-B", "type": "BIOLOGICAL" }, { "name": "Infanrix™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4003, "start_date": "2010-06-18", "completion_date": "2013-07-17", "has_results": true, "last_update_posted_date": "2018-07-12", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 63, "location_summary": "Dothan, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 59 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000974" }, { "nct_id": "NCT01424644", "title": "A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meningococcal Meningitis" ], "interventions": [ { "name": "Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine", "type": "BIOLOGICAL" }, { "name": "MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 801, "start_date": "2011-09", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Fremont, California • Madera, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Madera", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Dayton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01424644" }, { "nct_id": "NCT00835237", "title": "Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tetanus", "Acellular Pertussis", "Diphtheria", "Diphtheria-Tetanus-acellular Pertussis Vaccines" ], "interventions": [ { "name": "Boostrix®", "type": "BIOLOGICAL" }, { "name": "Decavac™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1332, "start_date": "2009-02-17", "completion_date": "2009-10-15", "has_results": true, "last_update_posted_date": "2020-01-03", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 24, "location_summary": "Tucson, Arizona • Los Angeles, California • DeLand, Florida + 21 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Stockbridge", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00835237" }, { "nct_id": "NCT00346073", "title": "Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acellular Pertussis", "Diphtheria", "Tetanus" ], "interventions": [ { "name": "Boostrix™", "type": "BIOLOGICAL" }, { "name": "ADACEL®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "19 Years to 64 Years" }, "enrollment_count": 2337, "start_date": "2006-07-13", "completion_date": "2007-03-07", "has_results": true, "last_update_posted_date": "2018-08-07", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 42, "location_summary": "Huntsville, Alabama • Chandler, Arizona • Mesa, Arizona + 36 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00346073" }, { "nct_id": "NCT02543918", "title": "A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ixekizumab", "type": "DRUG" }, { "name": "Boostrix®", "type": "DRUG" }, { "name": "Pneumovax®23", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 84, "start_date": "2015-09", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-01-06", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 3, "location_summary": "Daytona Beach, Florida • Evansville, Indiana • Dallas, Texas", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02543918" }, { "nct_id": "NCT01439165", "title": "Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis", "Whooping Cough" ], "interventions": [ { "name": "Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine", "type": "BIOLOGICAL" }, { "name": "Tetanus and Diphtheria Toxoids Adsorbed For Adult Use", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 1330, "start_date": "2011-11", "completion_date": "2017-02", "has_results": true, "last_update_posted_date": "2022-04-28", "last_synced_at": "2026-09-23T21:38:56.570Z", "location_count": 31, "location_summary": "Huntsville, Alabama • Jonesboro, Arkansas • Little Rock, Arkansas + 28 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01439165" } ] }